PCRX
HEALTHCAREPacira BioSciences Inc
$23.69-1.10 (-4.44%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PCRX Today?
No stock-specific AI insight has been generated for PCRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$18.80$27.64
$23.69
Fundamentals
Market Cap$932M
P/E Ratio182.2
EPS$0.13
Dividend Yield—
Dividend / Share—
ROE0.0%
Profit Margin0.0%
Debt / Equity—
Trading
Volume532K
Avg Volume (10D)—
Shares Outstanding39.3M
PCRX News
20 articles- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire Inc.·May 8, 2026
- Pacira BioSciences Mails Letter to StockholdersYahoo Finance·May 5, 2026
- Assessing Pacira BioSciences (PCRX) Valuation After Earnings Update And New EXPAREL Real World DataYahoo Finance·May 3, 2026
- Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/YYahoo Finance·May 1, 2026
- Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings ReleaseMotley Fool·May 1, 2026
- Pacira BioSciences Inc (PCRX) Q1 2026 Earnings Call Highlights: Strong Product Growth Amidst ...Yahoo Finance·May 1, 2026
- Pacira BioSciences Q1 Earnings Call HighlightsMarketbeat·May 1, 2026
- Pacira BioSciences, Inc. Q1 2026 Earnings Call SummaryMoby·May 1, 2026
- Pacira (PCRX) Q1 2026 Earnings Call TranscriptMotley Fool·Apr 30, 2026
- Pacira (PCRX) Q1 Earnings Miss EstimatesYahoo Finance·Apr 30, 2026
- Pacira BioSciences Reports First Quarter 2026 Financial ResultsYahoo Finance·Apr 30, 2026
- Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to ShareholdersYahoo Finance·Apr 28, 2026
- Do Options Traders Know Something About Pacira BioSciences Stock We Don't?Yahoo Finance·Apr 27, 2026
- Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip ArthroplastyYahoo Finance·Apr 27, 2026
- Can New EXPAREL Data and Proxy Fight Outcomes Reshape the Case For Investing In Pacira (PCRX)?Yahoo Finance·Apr 20, 2026
- Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026Yahoo Finance·Apr 16, 2026
- PharmaCorp Announces Investor Relations AgreementYahoo Finance·Apr 13, 2026
- Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty ProceduresGlobeNewswire Inc.·Apr 13, 2026
- Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 8, 2026
- PharmaCorp Rx Inc. To Present At The 2026 Bloom Burton & Co. Healthcare Investor ConferenceYahoo Finance·Apr 2, 2026
All 20 articles loaded
Price Data
Open$26.90
Previous Close$24.79
Day High$27.13
Day Low$23.47
52 Week High$27.64
52 Week Low$18.80
52-Week Range
$18.80$27.64
$23.69
Fundamentals
Market Cap$932M
P/E Ratio182.2
EPS$0.13
Dividend Yield—
Dividend / Share—
ROE0.0%
Profit Margin0.0%
Debt / Equity—
Trading
Volume532K
Avg Volume (10D)—
Shares Outstanding39.3M
About Pacira BioSciences Inc
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—